Shares in Shanghai Fosun Pharmaceutical (Group), a Chinese pharmaceutical manufacturer and distributor controlled by billionaire Guo Guangchang, fell by 1% today after the company said it had received domestic regulatory approval for a secondary stock listing in Hong Kong.
FORBES: Shanghai Fosun Pharma Shares Fall 1% On Approval Of Hong Kong Listing